niflumic acid has been researched along with Hypertrophy, Right Ventricular in 1 studies
Niflumic Acid: An analgesic and anti-inflammatory agent used in the treatment of rheumatoid arthritis.
Hypertrophy, Right Ventricular: Enlargement of the RIGHT VENTRICLE of the heart. This increase in ventricular mass is often attributed to PULMONARY HYPERTENSION and is a contributor to cardiovascular morbidity and mortality.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Forrest, AS | 1 |
| Joyce, TC | 1 |
| Huebner, ML | 1 |
| Ayon, RJ | 1 |
| Wiwchar, M | 1 |
| Joyce, J | 1 |
| Freitas, N | 1 |
| Davis, AJ | 1 |
| Ye, L | 1 |
| Duan, DD | 1 |
| Singer, CA | 1 |
| Valencik, ML | 1 |
| Greenwood, IA | 1 |
| Leblanc, N | 1 |
1 other study available for niflumic acid and Hypertrophy, Right Ventricular
| Article | Year |
|---|---|
Increased TMEM16A-encoded calcium-activated chloride channel activity is associated with pulmonary hypertension.
Topics: Animals; Anoctamin-1; Calcium Channel Blockers; Chloride Channel Agonists; Chloride Channels; Cycloo | 2012 |